Introduction Fibrosis is involved in up to one-third of deaths globally and can affect many
organ systems. Individuals with fibrosis in one organ may be more likely to develop fibrosis …

Idiopathic pulmonary fibrosis (IPF), characterized by irreversible scarring and progressive
destruction of the lung tissue, is one of the most common types of idiopathic interstitial …

The past two decades have been marked by a dramatic increase in the knowledge of the
genetics of human disease. The field of interstitial lung disease (ILD) genetics has expanded …

Idiopathic pulmonary fibrosis (IPF) is a progressive fatal disease of the lung with unknown
etiology and limited treatment options. It was once thought to be a slowly progressive …

The research of rare and devastating orphan diseases, such as idiopathic pulmonary
fibrosis (IPF) has been limited by the rarity of the disease itself. The prognosis is poor—the …

Genetic predisposition to pulmonary fibrosis has been confirmed by the discovery of several
gene mutations that cause pulmonary fibrosis. Although genetic sequencing of familial …

Introduction Idiopathic pulmonary fibrosis (IPF) is a complex, heterogeneous fibrotic lung
disease with median survival of 3 years. IPF can be defined in population studies, such as …

Idiopathic pulmonary fibrosis (IPF) is a rare disease of epithelial injury leading to persistent
fibrosis, remodelling of the lung parenchyma, and chronic respiratory failure [1]. IPF can be …

Objective. Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, irreversible, high‐
mortality lung disease, but its pathogenesis is still unclear. Our purpose was to explore …

2005; 288: L350–L358. 9. Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams
TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of …